Randomized Phase III Trial Of Doxorubicin/Cisplatin/Paclitaxel And G-CSF Versus Carboplatin/Paclitaxel In Patients With Stage III & IV Or Recurrent Endometrial Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cisplatin; Doxorubicin; Paclitaxel
- Indications Endometrial cancer
- Focus Therapeutic Use
- 28 May 2019 Biomarkers information updated
- 03 Mar 2010 New source identified and integrated (Robert H. Lurie Comprehensive Cancer Center, Northwestern University record no. GOG0209).
- 31 Oct 2009 New source identifed and integrated (Oregon Health and Science University Cancer Institute; SOL06055C)